Diabetes complications

Association of Elevated Lipoprotein(a) and Diabetes Mellitus With Survival Outcomes in Patients With Coronary Artery Disease: Findings From the CIN ‐ II and RED ‐ CARPET Cohorts

Diabetes Obes MetabPublished Cohort study

Authors' conclusion

In patients with CAD, elevated Lp(a) and DM act synergistically to increase the risk of cardiovascular and all-cause mortality, suggesting that both risks should be considered to integrate management.

Study context

Population
Coronary artery disease (CAD) patients from CIN-II and RED-CARPET cohorts (62.6 ± 10.7 years, 27.7% female)
Participants
65,547 patients
Exposure
Lp ≥30 mg/dL and/or diabetes mellitus (DM) vs Lp <30 mg/dL without DM
Outcome
Cardiovascular and all-cause mortality
Follow-up
Median 5.5 years
Methodological detailstwo cohorts (CIN-II and RED-CARPET), multivariable Cox regression
  • Two cohorts (CIN-II and RED-CARPET)
  • Multivariable Cox regression

Main finding

As reported in the abstract

Cardiovascular mortality
Each group vs Lp(a) <30 mg/dL without DMAdjusted hazard ratio (95% CI)P value
Lp(a) ≥30 mg/dL without DM
1.26(1.16–1.36)
P < 0.001
Lp(a) <30 mg/dL with DM
1.51(1.40–1.62)
P < 0.001
Lp(a) ≥30 mg/dL with DM
2.00(1.83–2.18)
P < 0.001
Lp(a) ≥30 mg/dL independently associated with CV mortality, aHR
1.28 (95% CI 1.20-1.35; p < 0.001)
DM independently associated with CV mortality, aHR
1.53 (95% CI 1.44-1.62; p < 0.001)
Significant additive interaction between elevated Lp(a) and DM on CV mortality; share of excess risk attributed
12%

Observational data: associations, not effects.

Further findings

All-cause mortality · median follow-up 5.5 years

Deaths from all causes (overall)
10 686 (16.3%)
Similar associations observed in all-cause mortality

Original publication

Association of Elevated Lipoprotein(a) and Diabetes Mellitus With Survival Outcomes in Patients With Coronary Artery Disease: Findings From the CIN ‐ II and RED ‐ CARPET Cohorts. Diabetes Obes Metab. Published 27 February 2026. doi:10.1111/dom.70603

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.